Peer-reviewed journal articles (25)

  1. 21. Maetens, M. M., Doumont, G., De Clercq, S., Francoz, S., Froment, P., Bellefroid, E., Klingmuller, U., Lozano, G., & Marine, J.-C. (2007). Distinct roles of Mdm2 and Mdm4 in red cell production. Blood, 109(6), 2630-2633.
  2. 22. Francoz, S., Froment, P., Bogaerts, S., De Clercq, S., Maetens, M. M., Doumont, G., Bellefroid, E., & Marine, J.-C. (2006). Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proceedings of the National Academy of Sciences of the United States of America, 103(9), 3232-3237. doi:10.1073/pnas.0508476103
  3. 23. Doumont, G., Martoriati, A., & Marine, J.-C. (2005). PTPRV is a key mediator of p53-induced cell cycle exit. Cell cycle (Georgetown, Tex.), 4(12), 1703-1705.
  4. 24. Doumont, G., Martoriati, A., Beekman, C., Bogaerts, S., Mee, P. J., Bureau, F., Colombo, E., Alcalay, M., Bellefroid, E., Marchesi, F., Scanziani, E., Pelicci, P. G., & Marine, J.-C. (2005). G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv. EMBO journal, 24(17), 3093-3103. doi:10.1038/sj.emboj.7600769
  5. 25. Martoriati, A., Doumont, G., Alcalay, M., Bellefroid, E., Pelicci, P. G., & Marine, J.-C. (2005). dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene, 24(8), 1461-1466. doi:10.1038/sj.onc.1208256
  6.   Papers published in national and international conferences or symposium proceedings (1)

  7. 1. Lavis, P., Pingitore, J., Doumont, G., Gabaret, A., Van Simaeys, G., Lacroix, S., Passon, N., Van Heymbeek, C., De Maeseneire, C., Huaux, F., Decaestecker, C., Salmon, I., Cardozo, A. K., Goldman, S., & Bondue, B. (2023). Fibroblast Activation Protein Inhibitor, a Promising Radiotracer inFibrogenesis. American journal of respiratory and critical care medicine,(207), A4704. doi:https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A4704
  8.   Theses and master's dissertations (1)

  9. 1. Doumont, G. (2005). Identification et caractérisation de nouveaux médiateurs de l'activité biologique de la protéine suppresseur de tumeur p53 (Unpublished doctoral dissertation). Université libre de Bruxelles, Faculté des Sciences – Chimie, Bruxelles.

  10. << Previous 1 2 Next >>